# Health Wanted: Cannabis | Emory University – Rollins School of Public Health > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/academic-cannabis-research-initiatives-emory-university/ > **Published:** 2026-04-17T22:05:32-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:08:01-04:00 > **Clinical Summary:** Explore academic cannabis research initiatives at Emory University advancing evidence-based medicine and clinical guidelines for cannabis therapeutics. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic ResearchAcademic MedicineEvidence-Based PracticeClinical Guidelines[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) Why This Matters Academic institutions launching dedicated [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) initiatives signals the field’s maturation toward [evidence-based medicine](https://cedclinic.com/digital-health-expertise-modern-challenge/). This represents institutional commitment to addressing the significant knowledge gaps that currently limit clinical decision-making in cannabis therapeutics. Clinical Summary Emory University’s Rollins School of Public Health has announced a new [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) initiative, joining other academic institutions in developing systematic approaches to studying [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). The program aims to address current evidence gaps through rigorous research methodologies. This institutional commitment reflects growing recognition that [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) requires the same evidence standards as other therapeutic interventions. Dr. Caplan’s Take “Academic legitimacy is essential for moving cannabis medicine beyond anecdote toward the evidence base we need to serve patients properly. When prestigious institutions like Emory commit resources, it accelerates the research that will ultimately improve patient outcomes.” Clinical Perspective 🧠 For clinicians, academic research programs provide the foundation for evidence-based practice recommendations. Patients should understand that while institutional research grows, current cannabis recommendations still rely heavily on clinical experience rather than robust trial data. This research infrastructure will eventually translate to better clinical guidelines and treatment protocols. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Health%20Wanted%3A%20Cannabis%20%7C%20Emory%20University%20-%20Rollins%20School%20of%20Public%20Health%20%40drcaplan&url=https%3A//sph.emory.edu/news/health-wanted-cannabis)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//sph.emory.edu/news/health-wanted-cannabis)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Health%20Wanted%3A%20Cannabis%20%7C%20Emory%20University%20-%20Rollins%20School%20of%20Public%20Health%20--%20via%20%40drcaplan.bsky.social%20https%3A//sph.emory.edu/news/health-wanted-cannabis)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://sph.emory.edu/news/health-wanted-cannabis](https://sph.emory.edu/news/health-wanted-cannabis) Table of Contents - [FAQ](#FAQ)[What is CED Clinical Relevance #70?](#What_is_CED_Clinical_Relevance_70) - [What type of content does this article cover?](#What_type_of_content_does_this_article_cover) - [Why is this marked as “New”?](#Why_is_this_marked_as_8220New8221) - [What does “Notable Clinical Interest” mean?](#What_does_8220Notable_Clinical_Interest8221_mean) - [Who should be interested in this content?](#Who_should_be_interested_in_this_content) - [Related](#Related) ## FAQ #### What is CED Clinical Relevance #70? CED Clinical Relevance #70 indicates “Notable Clinical Interest” regarding emerging findings or policy developments in cannabis medicine. This classification suggests the content contains information worth monitoring closely by healthcare professionals. #### What type of content does this article cover? This article focuses on cannabis news from CED Clinic, covering research, academic medicine, evidence-based practice, and clinical guidelines. The content appears to be targeted toward healthcare professionals interested in cannabis therapeutics. #### Why is this marked as “New”? The “New” designation indicates this is recently published or updated content. This helps healthcare professionals stay current with the latest developments in cannabis medicine and clinical practice. #### What does “Notable Clinical Interest” mean? “Notable Clinical Interest” suggests the article contains emerging findings or policy developments that could impact clinical practice. Healthcare providers should pay attention to these developments as they may influence treatment decisions or guidelines. #### Who should be interested in this content? This content is primarily designed for healthcare professionals, researchers, and clinicians interested in evidence-based cannabis medicine. The focus on clinical guidelines and academic medicine makes it particularly relevant for medical practitioners considering cannabis therapeutics. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Cannabis research is more than a scientific pursuit—it's a pathway to better health, informed … Discover how cannabis research extends beyond science to improve health outcomes and inform clinical practice. Learn More [Cannabis Business: Industry – University of Illinois LibGuides](https://cedclinic.com/cannabis-business-industry-trends-university-illinois/) Explore the cannabis industry landscape and its intersection with academic research and policy. [Explore Industry Insights](https://cedclinic.com/cannabis-business-industry-trends-university-illinois/) [CMS unveils new Medicare pilot for hemp, CBD products – Fierce Healthcare](https://cedclinic.com/medicare-pilot-hemp-cbd-coverage-expands-access/) Learn about new Medicare initiatives supporting hemp and [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/), reflecting evolving healthcare policies. [Read the Update](https://cedclinic.com/medicare-pilot-hemp-cbd-coverage-expands-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).